Syzygium australe extracts exhibit significant antioxidant and antidiabetic properties: a comprehensive analysis of the phytoconstituents

IF 3.4 Q2 PHARMACOLOGY & PHARMACY
Samah A. Youssef, Ahmed H. Elosaily, Nermeen F. Farag, Nabil Mohamed Selim, Mohammed A. Hussein, Hala M. El Hefnawy
{"title":"Syzygium australe extracts exhibit significant antioxidant and antidiabetic properties: a comprehensive analysis of the phytoconstituents","authors":"Samah A. Youssef,&nbsp;Ahmed H. Elosaily,&nbsp;Nermeen F. Farag,&nbsp;Nabil Mohamed Selim,&nbsp;Mohammed A. Hussein,&nbsp;Hala M. El Hefnawy","doi":"10.1186/s43094-025-00806-6","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Medicinal plants are well known for their health benefits. <i>Syzygium australe</i> (Brush Cherry) is considered a health-promoting food due to its high antioxidant capacity, which may help prevent cancer, cardiovascular diseases, and neurological disorders. Additionally, <i>S. australe</i> exhibits antidiabetic and antiobesity properties. </p><h3>Aim</h3><p>This study reviews the antioxidant and antidiabetic activities of <i>S. australe</i> fractions, along with their key phytoconstituents.</p><h3>Materials and methods </h3><p>The antioxidant activity of <i>S. australe</i> crude extract and fractions was assessed using DPPH (2,2-diphenyl-1-picrylhydrazyl-hydrate), ABTS (2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid)), FIC (ferrozine iron metal chelation), and FRAP (ferric reducing antioxidant power) assays. Their antidiabetic activity was evaluated using <i>α</i>-glucosidase, <i>α</i>-amylase, and lipase inhibition assays. Additionally, their TFC (total flavonoid content) and TPC (total phenolic content) were determined. The secondary metabolites were analysed using Triple TOF UPLC-ESI–MS/MS (ultra-performance liquid chromatography-electrospray ionization-time of flight-mass spectrometry).</p><h3>Results</h3><p>Our findings, for the first time, reveal that various <i>S. australe</i> extracts exhibit strong antidiabetic and antioxidant properties. The butanol and ethyl acetate fractions had the highest antidiabetic activity. Their respective IC₅₀ values against <i>α</i>-glucosidase, <i>α</i>-amylase, and lipase were 0.11–0.14 µg/mL, 0.06–0.09 µg/mL, and 26.5–30.79 ng/mL, respectively. Also, they showed powerful antioxidant activity. The IC<sub>50</sub> values of the ethyl acetate (19.93 ± 1 μg/mL) and butanol (38.7 μg/mL) fractions were significantly lower than those of the reference compounds, Trolox (24.42 ± 0.87 μg/mL) in the DPPH assay and EDTA (Ethylenediaminetetraacetic acid) (39.7 μg/mL) in the ferrozine iron metal chelation assay, respectively. They had a higher amount of TPC (397.65 ± 14.78, 253.32 ± 10.78 µg GAE/mg sample) and TFC (97.89 ± 4.98, 23.14 ± 1.11 µg RE/mg sample) of ethyl acetate and butanol, respectively. The significant phenolic and flavonoid substances found in these extracts may account for their strong antioxidant activity. Triple TOF UPLC-ESI–MS/MS analysis detected 18 phenolic acids, 19 derivatives, and 39 flavonoids. As a way to prevent or treat various disorders, these two extracts additionally served as a great source of antioxidant phytochemicals.</p><h3>Conclusion</h3><p>Ultimately, our findings strongly suggest that the phenolics of <i>S. australe</i> may be valuable for the development of antioxidant and antidiabetic medications.</p></div>","PeriodicalId":577,"journal":{"name":"Future Journal of Pharmaceutical Sciences","volume":"11 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://fjps.springeropen.com/counter/pdf/10.1186/s43094-025-00806-6","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1186/s43094-025-00806-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Medicinal plants are well known for their health benefits. Syzygium australe (Brush Cherry) is considered a health-promoting food due to its high antioxidant capacity, which may help prevent cancer, cardiovascular diseases, and neurological disorders. Additionally, S. australe exhibits antidiabetic and antiobesity properties.

Aim

This study reviews the antioxidant and antidiabetic activities of S. australe fractions, along with their key phytoconstituents.

Materials and methods

The antioxidant activity of S. australe crude extract and fractions was assessed using DPPH (2,2-diphenyl-1-picrylhydrazyl-hydrate), ABTS (2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid)), FIC (ferrozine iron metal chelation), and FRAP (ferric reducing antioxidant power) assays. Their antidiabetic activity was evaluated using α-glucosidase, α-amylase, and lipase inhibition assays. Additionally, their TFC (total flavonoid content) and TPC (total phenolic content) were determined. The secondary metabolites were analysed using Triple TOF UPLC-ESI–MS/MS (ultra-performance liquid chromatography-electrospray ionization-time of flight-mass spectrometry).

Results

Our findings, for the first time, reveal that various S. australe extracts exhibit strong antidiabetic and antioxidant properties. The butanol and ethyl acetate fractions had the highest antidiabetic activity. Their respective IC₅₀ values against α-glucosidase, α-amylase, and lipase were 0.11–0.14 µg/mL, 0.06–0.09 µg/mL, and 26.5–30.79 ng/mL, respectively. Also, they showed powerful antioxidant activity. The IC50 values of the ethyl acetate (19.93 ± 1 μg/mL) and butanol (38.7 μg/mL) fractions were significantly lower than those of the reference compounds, Trolox (24.42 ± 0.87 μg/mL) in the DPPH assay and EDTA (Ethylenediaminetetraacetic acid) (39.7 μg/mL) in the ferrozine iron metal chelation assay, respectively. They had a higher amount of TPC (397.65 ± 14.78, 253.32 ± 10.78 µg GAE/mg sample) and TFC (97.89 ± 4.98, 23.14 ± 1.11 µg RE/mg sample) of ethyl acetate and butanol, respectively. The significant phenolic and flavonoid substances found in these extracts may account for their strong antioxidant activity. Triple TOF UPLC-ESI–MS/MS analysis detected 18 phenolic acids, 19 derivatives, and 39 flavonoids. As a way to prevent or treat various disorders, these two extracts additionally served as a great source of antioxidant phytochemicals.

Conclusion

Ultimately, our findings strongly suggest that the phenolics of S. australe may be valuable for the development of antioxidant and antidiabetic medications.

澳大利亚合子提取物具有显著的抗氧化和抗糖尿病特性:植物成分的综合分析
药用植物对健康的益处是众所周知的。南樱被认为是一种促进健康的食物,因为它具有高抗氧化能力,可以帮助预防癌症、心血管疾病和神经系统疾病。此外,南芥还具有抗糖尿病和抗肥胖的特性。目的综述南洋参提取物的抗氧化和抗糖尿病活性及其主要成分。材料与方法采用DPPH(2,2-二苯基-1-picrylhydrazyl-hydrate)、ABTS (2,2 ' -azinobis(3-乙基苯并噻唑-6-磺酸))、FIC(铁金属螯合)和FRAP(铁还原抗氧化能力)法评价南芥粗提物及其组分的抗氧化活性。采用α-葡萄糖苷酶、α-淀粉酶和脂肪酶抑制试验评价其抗糖尿病活性。测定其总黄酮含量(TFC)和总酚含量(TPC)。二级代谢物采用三重TOF超高效液相色谱- esi - MS/MS(超高效液相色谱-电喷雾电离飞行时间质谱)进行分析。结果本研究首次揭示了澳大利亚南荆芥提取物具有较强的抗糖尿病和抗氧化活性。丁醇和乙酸乙酯部位的抗糖尿病活性最高。它们对α-葡萄糖苷酶、α-淀粉酶和脂肪酶的IC₅0值分别为0.11-0.14µg/mL、0.06-0.09µg/mL和26.5-30.79 ng/mL。此外,它们还显示出强大的抗氧化活性。乙酸乙酯组分(19.93±1 μg/mL)和丁醇组分(38.7 μg/mL)的IC50值分别显著低于对照化合物Trolox(24.42±0.87 μg/mL)和EDTA(乙二胺四乙酸)(39.7 μg/mL)。乙酸乙酯和丁醇的TPC(397.65±14.78,253.32±10.78µg RE/mg样品)和TFC(97.89±4.98,23.14±1.11µg RE/mg样品)含量较高。在这些提取物中发现的重要酚类和类黄酮物质可能是其强抗氧化活性的原因。三重TOF UPLC-ESI-MS /MS分析检测到18种酚酸、19种衍生物和39种黄酮类化合物。作为一种预防或治疗各种疾病的方法,这两种提取物还作为抗氧化植物化学物质的重要来源。结论该研究结果提示,南蛇藤的酚类物质可能在抗氧化和抗糖尿病药物的开发中具有重要的应用价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
44
审稿时长
23 weeks
期刊介绍: Future Journal of Pharmaceutical Sciences (FJPS) is the official journal of the Future University in Egypt. It is a peer-reviewed, open access journal which publishes original research articles, review articles and case studies on all aspects of pharmaceutical sciences and technologies, pharmacy practice and related clinical aspects, and pharmacy education. The journal publishes articles covering developments in drug absorption and metabolism, pharmacokinetics and dynamics, drug delivery systems, drug targeting and nano-technology. It also covers development of new systems, methods and techniques in pharmacy education and practice. The scope of the journal also extends to cover advancements in toxicology, cell and molecular biology, biomedical research, clinical and pharmaceutical microbiology, pharmaceutical biotechnology, medicinal chemistry, phytochemistry and nutraceuticals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信